• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动性失语症:转移性前列腺癌累及软脑膜:病例报告。

Dysphasia: metastatic prostate cancer to the leptomeninges: a case report.

机构信息

Department of Internal Medicine, Trinity Health Ann Arbor Hospital, 5301 McAuley Dr, Ypsilanti, MI, 48197, USA.

Department of Hematology and Oncology, Trinity Health Ann Arbor Hospital, 5301 McAuley Dr, Ypsilanti, MI, 48197, USA.

出版信息

J Med Case Rep. 2024 Oct 30;18(1):532. doi: 10.1186/s13256-024-04840-5.

DOI:10.1186/s13256-024-04840-5
PMID:39478563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11526645/
Abstract

BACKGROUND

Leptomeningeal metastasis occurs in 5% of patients with prostate cancer and indicates a very poor prognosis.

CASE PRESENTATION

A 60-year-old Caucasian male patient diagnosed with metastatic castration-resistant prostate cancer with sclerotic bone metastases and soft tissue metastases underwent multiple courses of chemotherapy and hormone therapy. The diagnosis of prostate cancer is based on elevated prostate-specific antigen levels and tissue biopsy. He subsequently presented with expressive aphasia. Nonspecific, diffuse irregular dural/pachymeningeal thickening enhancement was noted on magnetic resonance imaging. Upon evaluation by neurology, electroencephalogram was negative for an epileptiform correlate. The workup included a lumbar puncture to rule out infectious etiology. The patient's neurological status stabilized, and he was discharged home with a plan for continued therapy with abiraterone and prednisone. Due to advanced malignancy, the patient enrolled in hospice and died 3 weeks after hospital discharge.

CONCLUSIONS

Central nervous system metastasis occurs very rarely in prostate cancer. With the increase in life expectancy and advances in oncologic therapy for prostate cancer, physicians should be aware of and consider central nervous system metastasis in men aged 50 years and above.

摘要

背景

脑膜转移发生在 5%的前列腺癌患者中,预后极差。

病例介绍

一名 60 岁的白人男性患者,诊断为转移性去势抵抗性前列腺癌,伴骨硬化转移和软组织转移,接受了多次化疗和激素治疗。前列腺癌的诊断基于前列腺特异性抗原水平升高和组织活检。随后,他出现表达性失语。磁共振成像显示非特异性、弥漫性不规则硬脑膜/脑脊膜增厚增强。神经科评估时,脑电图未见癫痫样相关性。检查包括腰椎穿刺以排除感染性病因。患者的神经状态稳定,出院回家继续接受阿比特龙和泼尼松治疗。由于恶性肿瘤晚期,患者入住临终关怀病房,在出院后 3 周死亡。

结论

中枢神经系统转移在前列腺癌中非常罕见。随着预期寿命的延长和前列腺癌的肿瘤治疗进展,医生应意识到并考虑 50 岁及以上男性的中枢神经系统转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/11526645/956580db0da4/13256_2024_4840_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/11526645/567ee49d61c9/13256_2024_4840_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/11526645/9c6aa21ba0ec/13256_2024_4840_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/11526645/956580db0da4/13256_2024_4840_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/11526645/567ee49d61c9/13256_2024_4840_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/11526645/9c6aa21ba0ec/13256_2024_4840_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/11526645/956580db0da4/13256_2024_4840_Fig3_HTML.jpg

相似文献

1
Dysphasia: metastatic prostate cancer to the leptomeninges: a case report.运动性失语症:转移性前列腺癌累及软脑膜:病例报告。
J Med Case Rep. 2024 Oct 30;18(1):532. doi: 10.1186/s13256-024-04840-5.
2
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Leptomeningeal involvement by prostate carcinoma an ominous head of a well-known Hydra.前列腺癌的软脑膜受累是一只著名九头蛇不祥的头。
BMJ Case Rep. 2019 Sep 16;12(9):e230922. doi: 10.1136/bcr-2019-230922.
5
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.新诊断转移性去势敏感性前列腺癌患者中阿比特龙联合泼尼松添加到雄激素剥夺治疗后的患者报告结局(LATITUDE):一项国际性、随机 3 期临床试验。
Lancet Oncol. 2018 Feb;19(2):194-206. doi: 10.1016/S1470-2045(17)30911-7. Epub 2018 Jan 8.
6
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.镭-223 联合醋酸阿比特龙和泼尼松或泼尼松龙治疗去势抵抗性前列腺癌和骨转移患者(ERA 223):一项随机、双盲、安慰剂对照、III 期临床试验。
Lancet Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6.
7
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.计算机断层扫描是否为去势抵抗性前列腺癌转移评估的必要部分?来自共享平等获取区域癌症医院数据库的结果。
Cancer. 2016 Jan 15;122(2):222-9. doi: 10.1002/cncr.29748. Epub 2015 Oct 20.
8
A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.一例转移性癌症患者,其前列腺特异性抗原(PSA)水平显著升高,但经重复前列腺活检未检测到。
BMC Res Notes. 2014 Jan 29;7:64. doi: 10.1186/1756-0500-7-64.
9
Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: an effect of improved systemic therapy?激素难治性前列腺癌男性患者软脑膜受累表现的检出率增加:是全身治疗改善的结果吗?
J Med Imaging Radiat Oncol. 2008 Aug;52(4):376-81. doi: 10.1111/j.1440-1673.2008.01973.x.
10
A case report of prostate cancer with leptomeningeal metastasis.前列腺癌合并脑膜转移 1 例报告
Cancer Rep (Hoboken). 2022 Aug;5(8):e1463. doi: 10.1002/cnr2.1463. Epub 2021 Jun 5.

本文引用的文献

1
Intracranial Metastases from Prostate Carcinoma: Classification, Management, and Prognostication.颅内前列腺癌转移:分类、管理和预后。
World Neurosurg. 2020 Feb;134:e559-e565. doi: 10.1016/j.wneu.2019.10.125. Epub 2019 Oct 31.
2
Brain metastases from prostate cancer: A single-center experience.前列腺癌脑转移:单中心经验
Turk J Urol. 2018 Jun 5;45(4):279-283. doi: 10.5152/tud.2018.74555. Print 2019 Jul.
3
Brain Metastasis From Prostate Adenocarcinoma: Case Report and Review of Literature.前列腺腺癌脑转移:病例报告及文献综述
World J Oncol. 2012 Apr;3(2):83-86. doi: 10.4021/wjon442w. Epub 2012 Apr 23.
4
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis.前列腺癌患者转移部位的分布:一项基于人群的分析。
Prostate. 2014 Feb;74(2):210-6. doi: 10.1002/pros.22742. Epub 2013 Oct 16.
5
Seed, soil, and beyond: The basic biology of brain metastasis.种子、土壤及其他因素:脑转移的基础生物学
Surg Neurol Int. 2013 May 2;4(Suppl 4):S256-64. doi: 10.4103/2152-7806.111303. Print 2013.
6
Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis.前列腺癌脑转移:MRI时代的11年分析,重点关注影像特征、发病率和预后。
J Neuroimaging. 2014 Mar-Apr;24(2):161-6. doi: 10.1111/j.1552-6569.2012.00767.x. Epub 2012 Dec 28.
7
Frequency of brain metastases from prostate cancer: an 18-year single-institution experience.前列腺癌脑转移的频率:18 年单机构经验。
J Neurooncol. 2013 Jan;111(2):163-7. doi: 10.1007/s11060-012-0994-1. Epub 2012 Oct 25.
8
Metastatic patterns in adenocarcinoma.腺癌的转移模式。
Cancer. 2006 Apr 1;106(7):1624-33. doi: 10.1002/cncr.21778.
9
Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience.前列腺癌脑转移:MD安德森癌症中心的经验
Cancer. 2003 Jul 15;98(2):363-8. doi: 10.1002/cncr.11522.
10
Neurologic complications of prostate cancer.前列腺癌的神经系统并发症
Am Fam Physician. 2002 May 1;65(9):1834-40.